Use of a thienopyridone derivative in the treatment of autosomal dominant polycystic kidney disease (ADPKD)
US12310949B2 · kind B2 · utility
0Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 2, 2021 |
| Grant date | May 27, 2025 |
| Priority date | — |
| Expiry date | Apr 2, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P13/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of a thienopyridone derivative, or a pharmaceutical composition comprising the same, in the treatment of autosomal dominant polycystic kidney disease (ADPKD).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.